LISINOPRIL 40 MG TABLET
For 30 tablets
Pharmacies pay
$1.39 filed
30 × $0.04625 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$2.67 filed
30 × $0.08892 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.9× estimated
Medicare paid 1.9× what pharmacies pay.
Part D averages every strength and form sold under “Lisinopril” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.60 estimated
$1.39 + $0.21 (15%) + $5.00 fee per fill = $6.60
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LISINOPRIL 40 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lisinopril.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Major Pharmaceuticals and Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901).
FDA’s Established Pharmacologic Class for it is Angiotensin Converting Enzyme Inhibitor.
The NADAC file of 2026-10-14 prices it under 35 NDCs (National Drug Codes); the FDA directory lists 31 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1.39 for 30 tablets (30 × $0.04625 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 12 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Exelan Pharmaceuticals Inc. | 10 | $0.04625 per EA filed |
| Solco healthcare U.S., LLC | 4 | $0.04625 per EA filed |
| Lupin Pharmaceuticals, Inc. | 3 | $0.04625 per EA filed |
| Actavis Pharma, Inc. | 2 | $0.04625 per EA filed |
| BluePoint Laboratories | 2 | $0.04625 per EA filed |
| Camber Pharmaceuticals, Inc. | 2 | $0.04625 per EA filed |
| Chartwell RX, LLC | 2 | $0.04625 per EA filed |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901) | 2 | $0.04625 per EA filed |
| American Health Packaging | 1 | $0.04625 per EA filed |
| Legacy Pharmaceutical Packaging, LLC | 1 | $0.04625 per EA filed |
| Major Pharmaceuticals | 1 | $0.04625 per EA filed |
| Quallent Pharmaceuticals Health LLC | 1 | $0.04625 per EA filed |
| Not listed as a package in the FDA directory | 4 | $0.04625 per EA filed |
All 35 NDCs, with labeler and price
- 00172-3761-70 · not listed as a package in the FDA directory · $0.04625 per EA · eff. 2026-09-23 filed
- 00591-0409-01 · Actavis Pharma, Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 00591-0409-05 · Actavis Pharma, Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 00904-7200-61 · Major Pharmaceuticals · $0.04625 per EA · eff. 2026-09-23 filed
- 23155-0881-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901) · $0.04625 per EA · eff. 2026-09-23 filed
- 23155-0881-10 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901) · $0.04625 per EA · eff. 2026-09-23 filed
- 31722-0180-01 · Camber Pharmaceuticals, Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 31722-0180-10 · Camber Pharmaceuticals, Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 43547-0356-10 · Solco healthcare U.S., LLC · $0.04625 per EA · eff. 2026-09-23 filed
- 43547-0356-11 · Solco healthcare U.S., LLC · $0.04625 per EA · eff. 2026-09-23 filed
- 43547-0419-10 · Solco healthcare U.S., LLC · $0.04625 per EA · eff. 2026-09-23 filed
- 43547-0419-11 · Solco healthcare U.S., LLC · $0.04625 per EA · eff. 2026-09-23 filed
- 60687-0678-01 · American Health Packaging · $0.04625 per EA · eff. 2026-09-23 filed
- 60687-0678-11 · not listed as a package in the FDA directory · $0.04625 per EA · eff. 2026-09-23 filed
- 62135-0645-31 · Chartwell RX, LLC · $0.04625 per EA · eff. 2026-09-23 filed
- 62135-0645-90 · Chartwell RX, LLC · $0.04625 per EA · eff. 2026-09-23 filed
- 68001-0486-00 · BluePoint Laboratories · $0.04625 per EA · eff. 2026-09-23 filed
- 68001-0486-08 · BluePoint Laboratories · $0.04625 per EA · eff. 2026-09-23 filed
- 68180-0979-01 · Lupin Pharmaceuticals, Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 68180-0979-03 · Lupin Pharmaceuticals, Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 68180-0979-30 · Lupin Pharmaceuticals, Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 68645-0555-54 · not listed as a package in the FDA directory · $0.04625 per EA · eff. 2026-09-23 filed
- 68645-0593-54 · not listed as a package in the FDA directory · $0.04625 per EA · eff. 2026-09-23 filed
- 68645-0613-90 · Legacy Pharmaceutical Packaging, LLC · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0422-01 · Exelan Pharmaceuticals Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0422-10 · Exelan Pharmaceuticals Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0422-18 · Exelan Pharmaceuticals Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0422-45 · Exelan Pharmaceuticals Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0422-90 · Exelan Pharmaceuticals Inc. · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0733-01 · Exelan Pharmaceuticals, Inc · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0733-10 · Exelan Pharmaceuticals, Inc · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0733-18 · Exelan Pharmaceuticals, Inc · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0733-45 · Exelan Pharmaceuticals, Inc · $0.04625 per EA · eff. 2026-09-23 filed
- 76282-0733-90 · Exelan Pharmaceuticals, Inc · $0.04625 per EA · eff. 2026-09-23 filed
- 82009-0066-10 · Quallent Pharmaceuticals Health LLC · $0.04625 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
7 other products in the NADAC file share the FDA nonproprietary name lisinopril with LISINOPRIL 40 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LISINOPRIL 2.5 MG TABLET | $0.01404 per EA filed | $0.08892 per EA filed |
| LISINOPRIL 5 MG TABLET | $0.01433 per EA filed | $0.08892 per EA filed |
| LISINOPRIL 10 MG TABLET | $0.01815 per EA filed | $0.08892 per EA filed |
| LISINOPRIL 20 MG TABLET | $0.02536 per EA filed | $0.08892 per EA filed |
| LISINOPRIL 30 MG TABLET | $0.052 per EA filed | $0.08892 per EA filed |
| LISINOPRIL 40 MG TABLET this page | $0.04625 per EA filed | $0.08892 per EA filed |
| QBRELIS 1 MG/ML SOLUTION | $4.49739 per ML filed | $4.21567 per ML filed |
| ZESTRIL 10 MG TABLET | $12.52442 per EA filed | $12.56181 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-03-18, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 35 NDCs’ NADAC prices is $0.04625 per EA filed.
Of the 50 other products in FDA’s Angiotensin Converting Enzyme Inhibitor class priced per EA, 43 have a higher middle NADAC price and 7 a lower one. The one in the middle is AMLODIPINE-BENAZEPRIL 5-40 MG, at $0.14392 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $2.67 for 30 tablets, at an average of $0.08892 per EA in 2024 (2024-01-01 to 2024-12-31) for “Lisinopril”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 36,247,459 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for LISINOPRIL 40 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Lisinopril / Lisinopril: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB
- BENAZEPRIL HCL 10 MG TABLET
- ENALAPRIL MALEATE 10 MG TAB
- AMLODIPINE-BENAZEPRIL 10-20 MG
- RAMIPRIL 1.25 MG CAPSULE